Call 0808 800 0035

Free osteoporosis helpline


HRT supply shortages

Treatment | Osteoporosis Management

27 Aug 2019

There are ongoing shortages of several different forms of hormone replacement therapy (HRT).

The Department for Health and Social Care said it is aware of “ongoing supply issues” due to “manufacturing delays”.

Pharmaceutical companies and suppliers are reassuring people that it is a temporary issue they are working to resolve.

The current advice from the British Menopause Society (BMS) is to consider suitable alternatives for patients affected by the shortages:

“In the meantime, prescribers can continue to consider equivalent preparations that provide a similar dose to that which their patient is using.

“If an exact match is not possible, prescribers can seek guidance available on the practical prescribing chart on the BMS website and Menopause Matters website, to clarify equivalent doses.

“Consideration could also be given to prescribing estrogen and progestogen separately to make the closest match or find a suitable alternative.

“Different brands for the same medication may vary in appearance or excipients. However, they would provide equivalent amounts of hormones when used in similar doses.”

We’ve issued advice to people with osteoporosis who are affected by the shortages to talk to their GPs and pharmacists about suitable alternatives.

For further information about HRT shortages, including details about stock availability, visit the British Menopause Society website.

If you’d like to discuss this issue with our osteoporosis specialist nurses, we welcome healthcare professionals to contact our free Helpline on 0808 800 0035.